A Decade Of Sales Growth Lies Ahead For Vertex Pharmaceuticals By: Benzinga via Benzinga July 19, 2017 at 11:23 AM EDT Following strong Phase I and II data on Tuesday from three different triple combo regimens for cystic fibrosis, shares of Vertex ... Read More >> Related Stocks: Vertex Pharmaceuticals